Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Brendan L Hagerty"'
Autor:
Dana A Dominguez, Alyssa V Eade, John G Aversa, Brendan L Hagerty, Andrew M Blakely, Jeremy L Davis, Laleh G Melstrom, Jonathan M Hernandez
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e34714- (2024)
Background: Extrahepatic biliary neuroendocrine tumors (EBNETs) are rare. We aimed to characterize EBNETs including factors associated with survival. Methods: The National Cancer Database was queried for patients with EBNETs from 2004 to 2016. Patien
Externí odkaz:
https://doaj.org/article/6a64304254b6498581b173771098c397
Autor:
Brendan L. Hagerty, John G. Aversa, Dana A. Dominguez, Jeremy L. Davis, Jonathan M. Hernandez, James T. McCormick, Andrew M. Blakely
Publikováno v:
Diseases of the Colon & Rectum. 65:1206-1214
The role of adjuvant chemotherapy in resected stage II colon cancer remains controversial. Treatment recommendations rely largely on the presence of certain high-risk features for recurrence.We sought to define patient and clinicopathologic differenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::516368594e62ca95f1c5389e4078f34c
https://doi.org/10.1097/dcr.0000000000002074
https://doi.org/10.1097/dcr.0000000000002074
Publikováno v:
Biomolecules, Vol 10, Iss 7, p 973 (2020)
Mesothelin (MSLN) is a cell surface glycoprotein normally expressed only on serosal surfaces, and not found in the parenchyma of vital organs. Many solid tumors also express MSLN, including mesothelioma and pancreatic adenocarcinoma. Due to this favo
Externí odkaz:
https://doaj.org/article/1b905c2ad58a4b77bf8997bee806b742
Autor:
Brendan L. Hagerty, Andrew M. Blakely
Publikováno v:
Diseases of the Colon & Rectum. 66:e317-e317
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::257dcc9bfdf0c09d0ebe34917595652e
https://doi.org/10.1097/dcr.0000000000002858
https://doi.org/10.1097/dcr.0000000000002858
Autor:
Jeremy L. Davis, Jonathan M. Hernandez, Dana A. Dominguez, John G. Aversa, Andrew M. Blakely, Laurence P. Diggs, Brendan L. Hagerty, Mustafa Raoof
Publikováno v:
J Surg Oncol
BACKGROUND: Most gallbladder cancers are diagnosed after cholecystectomy for presumed benign disease, and nodal staging to inform subsequent treatment is therefore often lacking. We evaluated the association of lymphovascular invasion (LVI) with regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a1df50b6b7ba80621a676eb1c3bc56
https://doi.org/10.1002/jso.26160
https://doi.org/10.1002/jso.26160
Publikováno v:
Cancer Metastasis Reviews
Pancreatic cancer is the third leading cause of cancer death in the USA, and pancreatic ductal adenocarcinoma (PDA) constitutes 85% of pancreatic cancer diagnoses. PDA frequently metastasizes to the peritoneum, but effective treatment of peritoneal m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a99a78d78b5c90547509b6981e13f198
http://europepmc.org/articles/PMC7680314
http://europepmc.org/articles/PMC7680314
Autor:
Andrew M. Blakely, Brendan L. Hagerty, Philip H.G. Ituarte, Laurence P. Diggs, Jeremy L. Davis, Jonathan M. Hernandez, John G. Aversa, Dana A. Dominguez
Publikováno v:
J Gastrointest Surg
BACKGROUND: Locally advanced gastric cancer (LAGC) presents a therapeutic dilemma, particularly as it often involves adjacent organs through desmoplasia or true pathologic invasion. To obtain a margin-negative resection, these tumors require en bloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d001f24921f528468100a0fc24712b4
https://doi.org/10.1007/s11605-020-04719-y
https://doi.org/10.1007/s11605-020-04719-y
Autor:
Jian Xu, Brendan L. Hagerty, Serguei Kozlov, Wendi Custer Lawrence, N. Keith Collins, Nathan M Pate, Xianyu Zhang, T. Norene O'Sullivan, Theresa Guerin, Christine Alewine, Laura L. Bassel
Publikováno v:
Mol Cancer Ther
Antibody-based therapies designed for human use frequently fail to cross-react with the murine isoform of their target. Because of this problem, preclinical studies of antibody-based mesothelin (Msl)-targeted therapeutics in immunocompetent systems h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55ed0c5f9953cc131d02610d22f353ab
https://pubmed.ncbi.nlm.nih.gov/34315768
https://pubmed.ncbi.nlm.nih.gov/34315768
Autor:
Brendan L. Hagerty, John E. Mullinax, Andrew M. Blakely, Madeline B. Torres, Justin Drake, Jeremy L. Davis, Jonathan M. Hernandez
Publikováno v:
J Gastrointest Surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a353b6030a4f4f9c02f6313b7ded658
https://europepmc.org/articles/PMC9615106/
https://europepmc.org/articles/PMC9615106/
Autor:
Martha Quezado, Mark J. Roth, Armando C. Filie, David S. Schrump, Brendan L. Hagerty, Tanupriya Agrawal, Cara E. Monroe, Nadia Nasir
Publikováno v:
Diagnostic cytopathologyREFERENCES. 49(1)
Background Adenoid cystic carcinoma (AdCC) is an uncommon malignancy of the salivary gland characterized by slow growth, increased risk of recurrence and poor prognosis. The annual incidence in the United States is approximately 1200 cases per year a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19319b4782f0e9547de7d80d6481fc02
https://pubmed.ncbi.nlm.nih.gov/32770824
https://pubmed.ncbi.nlm.nih.gov/32770824